Skip to content
ClinCalc Pro
Menu
Biguanide

Metformin hydrochloride

Brand names: Glucophage, Metformin SR

A biguanide oral antidiabetic and the recommended first-line drug treatment for type 2 diabetes, also used in selected patients for prediabetes and polycystic ovary syndrome.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It lowers blood glucose chiefly by reducing hepatic gluconeogenesis and by increasing peripheral insulin sensitivity, without stimulating insulin secretion, so it does not itself cause hypoglycaemia.

Prescribing in practice

  • The rare but serious risk is lactic acidosis, so it is contraindicated or must be withheld in significant renal impairment, tissue hypoxia, acute dehydrating illness, and around iodinated contrast and major surgery.
  • Gastrointestinal upset is common; introducing it gradually with food or using a modified-release preparation improves tolerability.
  • Long-term use can reduce vitamin B12 absorption, which should be considered in patients with anaemia or neuropathy.

Monitoring

Monitor HbA1c and renal function (eGFR), with periodic vitamin B12 checks during prolonged therapy.

Counselling the patient

  • Take with or just after meals to reduce nausea and diarrhoea.
  • Stop temporarily and seek advice if you become acutely unwell with vomiting, diarrhoea or dehydration, or before a scan using contrast dye.
  • It does not usually cause low blood sugar on its own, but this can occur if combined with other diabetes medicines.

Evidence & guidelines

Metformin is the established first-line agent in NICE type 2 diabetes guidance, with long-term cardiovascular benefit demonstrated in the UKPDS.

Reference: NICE NG28; MHRA Drug Safety Update; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.

📚 MRCEM Revision

Featured in these MRCEM clinical pathways

Metformin hydrochloride is a core drug in the following exam-focused workups on our sister siteReviseMRCEM.

MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.